Replies to post #329417 on Bioelectronics Corp (BIEL)

[srinsocal]

That's one opinion, but not necessarily the correct one

The canine osteoarthritis study was published 2 months ago and BIEL likely had data from the results long before it was published.

Plenty of time to present the Study's impressive results to potential partners willing to invest in Vagus Nerve research. I don't see BIEL spending money on new patents unless there is a high probability of a near term benefit.

Patent applications are dated so BIEL's May 2024 application would have priority over any similar applications submitted at a later date.

If Clinicals are needed the duration of the Dog Study data collection, with just 14 days of therapy, was quite short. Since BIEL is now a know entity at the FDA, Cleared for 5 indications, the days of year long Clearance times are over. The Post-surgical Pain Clearance took 4 and a half months from submission to decision.

[gimmee greenbacks]

It's like they are starting over with a new device. "The market" is not impressed

It’s pretty clear this PR and what it portends went over your head.

Maybe think things through before making rash judgments?



BIEL